Share Wealth

Market
  • Markets Navigation
    Company Info.

    Marksans Pharma Ltd.

    Shareholding Pattern


    Market Cap.(`) 7665.26 Cr. P/BV 4.39 Book Value (`) 38.51
    52 Week High/Low ( ` ) 186/71 FV/ML 1/1 P/E(X) 28.78
    Book Closure 07/06/2023 EPS (`) 5.88 Div Yield (%) 0.30
    You can view the shareholding pattern for the latest two quarters for the company under two broad categories (Promoter & Non Promters).

    •  

    Shareholding Pattern as on 31/03/2024
    Summary statement holding of specified securities
    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held No. of shares underlying Depository Receipts Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) No. of shares underlying outstanding convertible securities (including warrants) Shareholding as a % assuming full conversion of convertible securities (as a percentage of diluted share capital) As a % of (A+B+C2) No. of Locked in shares - No.(a) No. of Locked in shares - As a % of total shares held(b) Number of equity shares held in dematerialized form
    (A) Promoter & Promoter Group 2 198711733 0 198711733 43.85 0 43.84 1000000 0.50 198711733
    (B) Public 254697 254452013 81314 254452013 56.15 81314 56.16 0 0.00 254161193
    (C1) Shares underlying DRs 0 0 0 0 0.00 0 0.00 0 0.00 0
    (C2) Shares held by Employee Trust 0 0 0 0 0.00 0 0.00 0 0.00 0
    (C) Non Promoter-Non Public 0 0 0 0 0.00 0 0.00 0 0.00 0
    Grand Total 254699 453163746 81314 453163746 100.00 81314 100.00 1000000 0.22 452872926

    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held No. of shares underlying Depository Receipts Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Number of equity shares held in dematerialized form
    Shareholding of Promoter and Promoter Group
    Indian
    Individuals / Hindu Undivided Family 2 198711733 0 198711733 43.85 198711733
    MARK SALDANHA 1 198491553 0 198491553 43.80 198491553
    SANDRA SALDANHA 1 220180 0 220180 0.05 220180
    Grand Total2198711733019871173343.85198711733
    Public Shareholding
    Institutions
    Mutual Funds 9 19162902 0 19162902 4.23 19162902
    QUANT MUTUAL FUND - QUANT SMALL CAP FUND 1 12641259 0 12641259 2.79 12641259
    Alternate Investment Funds 3 4281000 0 4281000 0.94 4281000
    Banks 3 2911 0 2911 0.00 911
    Foreign Portfolio Investors Category I 86 19922173 0 19922173 4.40 19922173
    Foreign Portfolio Investors Category II 11 1328582 0 1328582 0.29 1328582
    Foreign Direct Investment 1 49324324 0 49324324 10.88 49324324
    ORBIMED ASIA IV MAURITIUS FVCI LIMITED 1 49324324 0 49324324 10.88 49324324
    Sub Total1139402189209402189220.7494019892
    Non-Institutions
    Any Others (Specify) 2794 4873465 81314 4873465 1.08 4873465
    HUF 2744 4431551 0 4431551 0.98 4431551
    Clearing Members 41 399755 0 399755 0.09 399755
    Trusts 5 37919 0 37919 0.01 37919
    Employees 2 3500 0 3500 0.00 3500
    Firm 2 740 0 740 0.00 740
    Bodies Corporate 569 6908268 0 6908268 1.52 6907268
    Resident Individuals holding nominal share capital up to Rs. 2 lakhs 247326 119745334 0 119745334 26.42 119457514
    Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 40 20327387 0 20327387 4.49 20327387
    Non Resident Indians (NRIs) 3854 7874203 0 7874203 1.74 7874203
    Investor Education and Protection Fund (IEPF) 1 701464 0 701464 0.15 701464
    Sub Total2545841604301218131416043012135.40160141301
    Grand Total2546972544520138131425445201356.14254161193

  • Marksans Pharma Ltd.

    Products & Raw Material


    Market Cap.(`) 7665.26 Cr. P/BV 4.39 Book Value (`) 38.51
    52 Week High/Low ( ` ) 186/71 FV/ML 1/1 P/E(X) 28.78
    Book Closure 07/06/2023 EPS (`) 5.88 Div Yield (%) 0.30

    You can view the entire product & raw materials mix with Product names, Sales quantity & Value along with percentage contribution from each individual product.

    Product Report
    Product NameYearMonthSales QuantityUOMSales Value (` Crs.)Product Mix (%)
    Pharmaceuticals2023120.00-652.6899.61
    Scrap2023120.00-1.760.26
    Export Incentives2023120.00-0.760.11
    Raw Material Report
    Product NameYear/MonthSales QuantityUOMSales Value (` Crs)Product Mix (%)
    Raw Materials23/030.00Not Reported338.49100.00
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html